A new enteral diet, MHN-02, which contains abundant antioxidants and whey peptide, protects against carbon tetrachloride-inducedhepatitis

Journal of Parenteral and Enteral Nutrition

Volumn 35, Issue 4, 2011, Pages 516-522

  Takayanagi, Takehiko ^a   Sasaki, Hajime ^b   Kawashima, Akihiro ^b   Mizuochi, Yuichiro ^a   Hirate, Hiroyuki ^a   Sugiura, Takeshi ^a   Azami, Takafumi ^a   Asai, Kiyofumi ^a   Sobue, Kazuya ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b MEIJI DAIRIES CORPORATION   (Japan)

Author keywords

Antioxidant effect; Hepatitis; Immunonutrition; Whey peptide

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; CYTOKINE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; LIVER ENZYME; MHN 02; SCAVENGER; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERIC FEEDING; ENZYME ACTIVITY; HEPATITIS; INFLAMMATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LETHALITY; LIVER; LIVER HISTOLOGY; LIVER INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SURVIVAL; WHEY;

ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; CARBON TETRACHLORIDE; DIET; DRUG-INDUCED LIVER INJURY; ENTERAL NUTRITION; FREE RADICAL SCAVENGERS; HEPATITIS; INTERLEUKIN-6; L-LACTATE DEHYDROGENASE; LIVER; MALE; MILK PROTEINS; MODELS, ANIMAL; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 80051880225     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607110381599     Document Type: Article

References (36)

1. De Gasperi A, Corti A, Mazza E, Prosperi M, Amici O, Bettinelli L. Acute liver failure: managing coagulopathy and the bleeding diathesis. Transplant Proc. 2009;41:1256-1259.
2. Schilsky ML, Honiden S, Arnott L, Emre S. ICU management of acute liver failure. Clin Chest Med. 2009;30:71-87, viii.
3. Uehleke H, Werner T. A comparative study on the irreversible binding of labeled halothane trichlorofluoromethane, chloroform, and carbon tetrachloride to hepatic protein and lipids in vitro and in vivo. Arch Toxicol. 1975;34:289-308.
4. Pohl LR, George JW. Identification of dichloromethyl carbene as a metabolite of carbon tetrachloride. Biochem Biophys Res Commun. 1983;117:367-371. (Pubitemid 14177572)
5. Orfila C, Lepert JC, Alric L, et al. Expression of TNF-alpha and immunohistochemical distribution of hepatic macrophage surface markers in carbon tetrachloride-induced chronic liver injury in rats. Histochem J. 1999;31:677-685.
6. Orfila C, Lepert JC, Alric L, Carrera G, Beraud M, Pipy B. Immunohistochemical distribution of activated nuclear factor kap-paB and peroxisome proliferator-activated receptors in carbon tetrachloride-induced chronic liver injury in rats. Histochem Cell Biol. 2005;123:585-593. (Pubitemid 41126077)
7. Sheikh N, Batusic DS, Dudas J, et al. Hepcidin and hemojuvelin gene expression in rat liver damage: in vivo and in vitro studies. Am J Physiol Gastrointest Liver Physiol. 2006;291:G482-G490. (Pubitemid 44330169)
8. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A. Protein carbonylation in human diseases. Trends Mol Med. 2003;9:169-176. (Pubitemid 36626706)
9. Neuman MG. Cytokines-central factors in alcoholic liver disease. Alcohol Res Health. 2003;27:307-316. (Pubitemid 40685570)
10. Sriskandan S, Cohen J. The pathogenesis of septic shock. J Infect. 1995;30:201-206.
11. SanGiovanni JP, Chew EY. The role of omega-3 long-chain polyun-saturated fatty acids in health and disease of the retina. Prog Retin Eye Res. 2005;24:87-138. (Pubitemid 39535157)
12. Yamaguchi M, Uchida M. MHN-02, liquid food combined with whey peptides, suppresses interleukin-6 release after intestinal ischemia/reperfusion in rats. Milk Science. 2009;57:87-90.
13. Yamaji T, Kume H. Hepatoprotective effects of whey protein and whey peptides on hepatitis. Milk Science. 2008;56:115-118.
14. Young TH, Tang HS, Chao YC, et al. Quantitative rat liver function test by galactose single point method. Lab Anim. 2008;42:495-504.
15. Leon OS, Menendez S, Merino N, et al. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators Inflamm. 1998;7:289-294. (Pubitemid 28419524)
16. Borkham-Kamphorst E, Kovalenko E, van Roeyen CR, et al. Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury. Lab Invest. 2008;88:1090-1100.
17. Berger ML, Bhatt H, Combes B, Estabrook RW. CCl4-induced toxicity in isolated hepatocytes: the importance of direct solvent injury. Hepatology. 1986;6:36-45. (Pubitemid 16137840)
18. Dingchao H, Zhiduan Q, Liye H, Xiaodong F. The protective effects of high-dose ascorbic acid on myocardium against reper-fusion injury during and after cardiopulmonary bypass. Thorac Cardiovasc Surg. 1994;42:276-278. (Pubitemid 24339861)
19. van Poppel G, Kardinaal A, Princen H, Kok FJ. Antioxidants and coronary heart disease. Ann Med. 1994;26:429-434.
20. Burton GW, Joyce A, Ingold KU. Is vitamin E the only lipid-solu-ble, chain-breaking antioxidant in human blood plasma and eryth-rocyte membranes? Arch Biochem Biophys. 1983;221:281-290. (Pubitemid 13128239)
21. Scarpa M, Rigo A, Maiorino M, Ursini F, Gregolin C. Formation of alpha-tocopherol radical and recycling of alpha-tocopherol by ascorbate during peroxidation of phosphatidylcholine liposomes: an electron paramagnetic resonance study. Biochim Biophys Acta. 1984;801:215-219. (Pubitemid 14007744)
22. Nathens AB, Neff MJ, Jurkovich GJ, et al. Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg. 2002;236:814-822. (Pubitemid 35403237)
23. Venardos K, Harrison G, Headrick J, Perkins A. Selenium supplementation and ischemia-reperfusion injury in rats. Redox Rep. 2004;9:317-320. (Pubitemid 40185435)
24. Berger MM, Reymond MJ, Shenkin A, et al. Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial. Intensive Care Med. 2001;27:91-100. (Pubitemid 32208974)
25. Kinnula VL, Crapo JD. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care Med. 2003;167:1600-1619. (Pubitemid 36760673)
26. Noor R, Mittal S, Iqbal J. Superoxide dismutase-applications and relevance to human diseases. Med Sci Monit. 2002;8:RA210-RA215.
27. Fukai T, Folz RJ, Landmesser U, Harrison DG. Extracellular super-oxide dismutase and cardiovascular disease. Cardiovasc Res. 2002;55:239-249. (Pubitemid 34775274)
28. Slater TF. Necrogenic action of carbon tetrachloride in the rat: a speculative mechanism based on activation. Nature. 1966;209:36-40.
29. Shi J, Aisaki K, Ikawa Y, Wake K. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am J Pathol. 1998;153:515-525. (Pubitemid 28373662)
30. Czaja MJ, Xu J, Alt E. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology. 1995;108:1849-1854.
31. Covington MB. Omega-3 fatty acids. Am Fam Physician. 2004;70:133-140. (Pubitemid 38890768)
32. Mead A, Atkinson G, Albin D, et al. Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease-evidence from systematic reviews of randomized controlled trials (second update, January 2006). J Hum Nutr Diet. 2006;19:401-419. (Pubitemid 44741532)
33. Calder PC. n-3 fatty acids, inflammation, and immunity-relevance to postsurgical and critically ill patients. Lipids. 2004;39:1147-1161.
34. Miller AM, van Bekkum DW, Kobb SM, McCrohan MB, Knaan-Shanzer S. Dietary fish oil supplementation alters LTB4:LTB5 ratios but does not affect the expression of acute graft versus host disease in mice. Prostaglandins Leukot Essent Fatty Acids. 1993;49:561-568. (Pubitemid 23236515)
35. Sato N, Kozar RA, Zou L, et al. Peroxisome proliferator-activated receptor gamma mediates protection against cyclooxygenase-2-induced gut dysfunction in a rodent model of mesenteric ischemia/ reperfusion. Shock. 2005;24:462-469. (Pubitemid 41567359)
36. Boros M, Bako L, Nagy S. Effect of antioxidant therapy on cycloox-ygenase-derived eicosanoid release during intestinal ischemia-reperfusion. Eur Surg Res. 1991;23:141-150.